Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal magnesium sulfate versus dexmedetomidine for postoperative pain after laparoscopic cholecystectomy
IRCT20180103038196N9Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate, dexmedetomidine and bupivacaine in postoperative pain (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Dec 2025; status: completed.
02
Drugs
magnesium sulfatedexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20180103038196N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038196N9.